5th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 18-20 | Hybrid Event
Delivery of Genes, Drugs, or Cells
Gene delivery systems are vital for treating human genetic conditions with gene therapy. Gene therapy is a one-of-a-kind method of curing any ailment by using an adaptable gene. Gene therapy is a promising treatment option for a variety of diseases, including hereditary disorders, viral infections, and cancer. The effective effects of gene delivery systems are dependent on the ability to target gene delivery systems in a variety of ways. For the practical use of gene therapy, certain viable gene delivery techniques have recently been reported. Various disorders induced by environmental chemical poisons, bacterial infections, viral invasions, malignant tumours, and endogenous genetic abnormalities are treated by drug and gene delivery systems. Although the majority of contemporary gene delivery technologies are based on mammalian viruses or synthetic materials meant to mimic virus gene delivery features, different biological systems can still be used as gene delivery vectors.
Thomas J Webster
Interstellar Therapeutics, United States
Steve Busby
University of Birmingham, United Kingdom
Murray Moo Young
University of Waterloo, Canada
Julia Sidorova
Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Luis Jesus Villarreal Gomez
Universidad Autonoma de Baja California, Mexico
Assad Al Ammar
Specialty Enzymes and Probiotics, United States
Tina Moller Tagmose
Novo Nordisk A/S, DenmarkSubmit your abstract Today
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain